(Q51571127)

English

5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside reduces intimal hyperplasia of tissue engineering blood vessel by inhibiting phenotype switch of vascular smooth muscle cell.

scientific article published on 7 January 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside reduces intimal hyperplasia of tissue engineering blood vessel by inhibiting phenotype switch of vascular smooth muscle cell. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

tissue engineering

1 reference

based on heuristic

inferred from title

author name string

Yangxiao Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

Ge Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

Wen Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

Mingcan Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

Chuhong Zhu

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

publication date

7 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Journal of Biomedical Materials Research Part B

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

105

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

744-752

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Coronary artery bypass grafting hemodynamics and anastomosis design: a biomedical engineering review

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after coronary stenting

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Arteriovenous access failure: more than just intimal hyperplasia?

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Vascular smooth muscle phenotypic diversity and function

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Cellular phenotypes in human stenotic lesions from haemodialysis vascular access

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Molecular regulation of vascular smooth muscle cell differentiation in development and disease

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agent for therapy of patients with acute lymphoblastic leukemia: are we there and are there pitfalls?

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

AMPK: a target for drugs and natural products with effects on both diabetes and cancer

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

AICAR induces astroglial differentiation of neural stem cells via activating the JAK/STAT3 pathway independently of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Effect of AICAR treatment on glycogen metabolism in skeletal muscle

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

The construction of tissue-engineered blood vessels crosslinked with adenosine-loaded chitosan/β-cyclodextrin nanoparticles using a layer-by-layer assembly method.

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Intimal hyperplasia: slow but deadly

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

AMPK in Health and Disease

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Activation of AMP-activated protein kinase (AMPK) inhibits fatty acid synthesis in bovine mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Subtilase cytotoxin, produced by Shiga-toxigenic Escherichia coli, transiently inhibits protein synthesis of Vero cells via degradation of BiP and induces cell cycle arrest at G1 by downregulation of cyclin D1

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

ECM remodeling in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33585

21 January 2018

Identifiers

10.1002/JBM.B.33585

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26743435

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51571127&oldid=2034789564"